NCT06326346View on ClinicalTrials.gov

GIST Oral Paclitaxel(Liporaxel)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

Liporaxel

Liporaxel 200mg/m2 twice daily orally on day 1, 8, and 15 every 4 weeks (1 cycle = 4 weeks)

Trial Locations (1)

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT06326346 - GIST Oral Paclitaxel(Liporaxel) | Biotech Hunter | Biotech Hunter